Piracetam

other

What is it

Piracetam is the original racetam, synthesized in 1964 by Belgian chemist Corneliu Giurgea, who coined the term 'nootropic.' It is a cyclic derivative of GABA used in many countries as a prescription medication for cognitive impairment, dementia, myoclonus, and certain childhood conditions. In the US, the FDA does not recognize piracetam as a dietary supplement ingredient.

How it works

Piracetam's mechanism is not fully understood. It is a positive allosteric modulator of AMPA glutamate receptors (similar to but weaker than aniracetam) and influences acetylcholine signaling. It also affects membrane fluidity, which may improve neuronal function in aged or damaged brains. Piracetam has been reported to improve cerebral microcirculation and reduce red blood cell rigidity, which has been proposed as a mechanism for its use in vascular dementia and certain hemorheological conditions. Piracetam is water-soluble, well absorbed orally, with a long half-life (5-6 hours) and crosses the blood-brain barrier slowly. Most clinical evidence comes from European studies in elderly patients with cognitive decline; effects in healthy adults are less established.

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Cognitive impairment in elderly / dementia

Grade B

Good evidence

Multiple European clinical trials have shown modest improvements in cognitive function in elderly patients with mild cognitive impairment or dementia. Effect sizes are small to moderate, and methodology varies.

Myoclonus

Grade B

Good evidence

Piracetam is an established adjunctive treatment for cortical myoclonus in multiple European countries, with clinical trials supporting its use.

Stroke recovery / vascular dementia

Grade C

Moderate evidence

Some clinical trials have shown benefits in cognitive and motor recovery after stroke. Other trials have been negative; results depend on study design and patient selection.

Breath-holding spells in children / sickle cell disease

Grade C

Moderate evidence

Small trials and case series have supported use for certain pediatric conditions and red-cell rigidity effects in sickle cell disease.

Cognitive enhancement in healthy adults

Grade D

Mixed evidence

Despite its popularity as a nootropic, evidence for clinically meaningful cognitive enhancement in healthy adults is limited and inconsistent.

3 commercial forms

Piracetam tablets / capsules

High oral bioavailability; water-soluble

Standard pharmaceutical form. Used in most clinical trials.

Piracetam powder

Same absorption profile

Allows precise dosing; bitter taste. Common in nootropic supplements.

Piracetam oral solution

Liquid form

Available in some countries for patients with swallowing difficulties.

Dosage

Clinical doses range from 1200 to 4800 mg per day, divided into 2-3 doses. Studies for cognitive impairment have commonly used 2400-4800 mg per day. Supplement products typically suggest 800-1600 mg per serving. Lower doses are typically used for prolonged supplementation.

When and how to take it

Doses are typically split between morning, midday, and afternoon. Avoid late-evening doses if you experience sleep disturbance. Piracetam can be taken with or without food. Some users co-supplement with choline (alpha-GPC, CDP-choline) to reduce headache risk.

Safety

Piracetam has an excellent safety profile in clinical studies. Side effects, when they occur, include nervousness, headache, insomnia, drowsiness, hyperactivity (especially in children), nausea, and weight gain. Long-term clinical use of decades in some countries has not shown serious adverse effects at recommended doses.

Who should be cautious

Avoid in pregnancy and breastfeeding (specifically, manufacturers usually recommend against use). People with kidney impairment require dose adjustment; piracetam is excreted by the kidneys. Caution in people with bleeding disorders or on anticoagulants. In the US, the FDA has stated piracetam does not qualify as a dietary supplement ingredient.

Interactions

Piracetam may interact with thyroid hormones (with reports of confusion or sleep changes when combined), anticoagulants (potential additive antiplatelet effects), and CNS depressants. Co-supplementation with choline sources is common in nootropic communities to reduce headache risk.

Frequently asked questions

Is piracetam legal?⌄

It is a prescription medication in many European countries but not approved or recognized in the US as a drug or supplement. Legal status varies by country.

Does piracetam make you smarter?⌄

It has shown modest benefits in cognitively impaired elderly patients. Evidence for cognitive enhancement in healthy young adults is weak and inconsistent.

What is the loading dose?⌄

Some users start with higher doses (4-9 g per day) for the first 1-2 days, then taper to maintenance. Clinical evidence for this approach is limited.

Should I take choline with piracetam?⌄

Many users find that co-supplementing with choline sources (alpha-GPC, CDP-choline) reduces racetam-related headaches and may improve effects.

Is piracetam safe long-term?⌄

Clinical use spans decades in some countries with a good safety profile. Long-term outcomes in healthy users for cognitive enhancement are less documented.

References

  • Piracetam (Wikidata) — Wikidata link
  • Piracetam (PubChem CID 4843) — PubChem link
  • Piracetam (ChEBI 32010) — ChEBI link

Track Piracetam with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.